The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial.
Autorzy:
Romano A; Dipartimento di Specialità medico-Chirurgiche, CHIRMED, Sezione di Ematologia, Università degli studi di Catania, Catania, Italy. Pavoni C; Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy. Di Raimondo F; Dipartimento di Specialità medico-Chirurgiche, CHIRMED, Sezione di Ematologia, Università degli studi di Catania, Catania, Italy. Tarella C; Onco-Hematology Unit, Istituto Europeo di Oncologia, Milan, Italy.; Università degli Studi di Milano, Milano, Italy. Viviani S; Ematologia e onco-ematologia pediatrica, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy. Rossi A; Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy. Patti C; Ematologia, Azienda Villa Sofia-Cervello, Palermo, Italy. Picardi M; Ematologia, Università Federico II, Napoli, Italy. Cantonetti M; Oncoematologia, Policlinico Tor Vergata, Roma, Italy. La Nasa G; Ematologia, Ospedale R.Binaghi, Cagliari, Italy. Trentin L; Ematologia Dipartimento di Medicina, Università di Padova, Padova, Italy. Bolis S; Ematologia, Ospedale San Gerardo, Monza, Italy. Zoli V; Ematologia, Ospedale S. Camillo, Roma, Italy. Gavarotti P; Ematologia Universitaria, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Italy. Corradini P; Dipartimento di oncologia-ematologia, Università degli Studi di Milano, Milano, Italy. CimminielloM; Divisione Universitaria di Ematologia, Ospedale San Carlo, Potenza, Italy. Schiavotto C; Ematologia, Presidio Ospedaliero S. Bortolo, Vicenza, Italy. Parvis G; Divisione Universitaria Medicina Interna, AO San Luigi, Orbassano, Italy. Zanotti R; Divisione di Medicina, Unità di Ematologia, Azienda Ospedaliera Universitaria Integrata, Verona, Italy. Gini G; Divisione Universitaria di Ematologia, Nuovo Ospedale Torrette, Ancona, Italy. Ferreri AJM; Unità di Ricerca Clinica Linfomi, IRCSS Ospedale San Raffaele, Milano, Italy. Viero P; Ematologia, Ospedale dell'Angelo, Mestre, Italy. Chauvie S; Medicina Nucleare Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy. Biggi A; Medicina Nucleare Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy. Massimo Gianni A; Onco-Hematology Unit, Istituto Europeo di Oncologia, Milan, Italy.; Università degli Studi di Milano, Milano, Italy. Gallamini A; Department recherch e innovation et statistique, Centre A. Lacassagne, Nice, France. Rambaldi A; Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Dipartimento di oncologia-ematologia, Università degli Studi di Milano, Milano, Italy.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 Dec; Vol. 9 (23), pp. 8735-8746. Date of Electronic Publication: 2020 Nov 06.
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis.
Allojenik Hematopoetik Kök Hücre Alıcılarında Sitomegalovirüsün Primer Profilaksisi için Letermovirin Etkililiği ve Güvenirliğine İlişkin Gerçek Yaşam Verileri: Tek Merkezli Bir Analiz.
BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR HODGKIN LYMPHOMA: A REAL‐LIFE EXPERIENCE BY FONDAZIONE ITALIANA LINFOMI (FIL)
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients.
Autorzy:
D'Arena G; a Hematology and Stem Cell Transplantation Unit , IRCCS-CROB, Referral Cancer Center of Basilicata , Rionero in Vulture , Italy. Simeon V; b Laboratory of Preclinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata , Rionero in Vulture , Italy. Laurenti L; c Hematology and Stem Cell Transplantation Unit , Catholic University of 'Sacred Hearth' , Rome , Italy. CimminielloM; d Hematology and Stem Cell Transplantation Unit , ' S. Carlo' Hospital , Potenza , Italy. Innocenti I; c Hematology and Stem Cell Transplantation Unit , Catholic University of 'Sacred Hearth' , Rome , Italy. Gilio M; e Rheumatology Department , ' S. Carlo' Hospital , Potenza , Italy.; f Department of Health Sciences , University of Catanzaro 'Magna Graecia' , Catanzaro , Italy. Padula A; e Rheumatology Department , ' S. Carlo' Hospital , Potenza , Italy. Vigliotti ML; g Hematology Unit , ' S. Sebastiano' Hospital , Caserta , Italy. De Lorenzo S; h Hematology and Stem Cell Transplantation Unit , ' A. Tortora' Hospital , Pagani , Italy. Loseto G; i Hematology Unit , IRCCS National Cancer Research Institute 'Giovanni Paolo II' , Bari , Italy. Passarelli A; j Department of Biomedical Sciences and Human Oncology , ' Aldo Moro' University , Bari , Italy. Di Minno MND; k Department of Clinical Medicine and Surgery , Regional Service Centre of Coagulation Disorders, 'Federico II' University , Naples , Italy.; l Unit of Cell and Molecular Biology in Cardiovascular Diseases , IRCCS Monzino Cardiology Center , Milan , Italy. Tucci M; j Department of Biomedical Sciences and Human Oncology , ' Aldo Moro' University , Bari , Italy. De Feo V; m Department of Pharmacology , University of Salerno , Salerno , Italy. D'Auria F; n Laboratory of Clinical and Advanced Diagnostics, IRCCS-CROB, Referral Cancer Center of Basilicata , Rionero in Vulture , Italy. Silvestris F; j Department of Biomedical Sciences and Human Oncology , ' Aldo Moro' University , Bari , Italy. Di Minno G; k Department of Clinical Medicine and Surgery , Regional Service Centre of Coagulation Disorders, 'Federico II' University , Naples , Italy. Musto P; o Scientific Direction, IRCCS-CROB , Referral Cancer Center of Basilicata , Rionero in Vulture , Italy.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2017 Nov; Vol. 58 (11), pp. 2633-2641. Date of Electronic Publication: 2017 Apr 03.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HODGKIN LYMPHOMA WITH LARGE NODAL MASS IN COMPLETE METABOLIC RESPONSE AFTER ABVD. FINAL ANALYSIS OF THE RANDOMIZED HD0607 TRIAL.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
